How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? - ScienceDirect
Health Screening – Raised Cancer Markers CEA, Ca 19-9 and aFP
PPT - CA 19-9 PowerPoint Presentation, free download - ID:4169447
Tumor Markers in Pancreatic Cancer: 2013
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas – A retrospective tumor marker prognostic study - ScienceDirect
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
CA 19-9 tumor marker | pancreatic cancer diagnosis | tumor marker (Everything you need to know) - YouTube
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
Tumor Marker CA 19-9 for Assessing Pancreatic Cancer Response - Cancer Therapy Advisor
Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect
Tumor markers- Dr. Enja Amarnath Reddy | PPT
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
Tumour marker CA 19-9 - Pancreatic Cancer - little known - little heeded
Comparison of the Normal CA 19-9 Level Group and Elevated CA 19-9 Level... | Download Scientific Diagram
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future